Promis Neurosciences Inc (PMN)

Aug 20, 2025

ProMIS Neurosciences Reports Increased R&D Expenses and Net Loss - MSN

Aug 20, 2025

Aug 20, 2025

Promis Neurosciences chief scientific officer buys $14,595 in shares - MSN

Aug 20, 2025

Aug 20, 2025

ProMIS Neurosciences Announces $17.99M At The Market Offering to Enhance Financial Flexibility - AInvest

Aug 20, 2025

Aug 19, 2025

ProMIS Neurosciences Announces At The Market Offering - TipRanks

Aug 19, 2025

Aug 19, 2025

ProMIS Neurosciences Inc. Enters Reversal Setup in Weekly ChartsJuly 2025 Intraday Action & Risk Controlled Swing Alerts - kangso.co.kr

Aug 19, 2025

Aug 19, 2025

Candlestick Signal Suggests Reversal in ProMIS Neurosciences Inc.July 2025 Final Week & Free Fast Entry Momentum Trade Alerts - 선데이타임즈

Aug 19, 2025

Aug 17, 2025

Traders Consider Averaging Down in ProMIS Neurosciences Inc.2025 Fundamental Recap & Weekly High Conviction Trade Ideas - beatles.ru

Aug 17, 2025

Aug 16, 2025

Why ProMIS Neurosciences Inc. stock attracts strong analyst attentionJuly 2025 Pullbacks & High Win Rate Trade Tips - thegnnews.com

Aug 16, 2025

Aug 16, 2025

Market reaction to ProMIS Neurosciences Inc.’s recent newsStop Loss & Weekly Sector Rotation Insights - Newser

Aug 16, 2025

Aug 16, 2025

ProMIS Neurosciences: Promising Alzheimer's Treatment and Strong Financials Drive Buy Rating - AInvest

Aug 16, 2025

Aug 14, 2025

What makes ProMIS Neurosciences Inc. stock price move sharplyPortfolio Performance Summary & Free Long-Term Investment Growth Plans - Newser

Aug 14, 2025

Aug 14, 2025

ProMIS Neurosciences Inc. Building a Base Near Support2025 Market Sentiment & Safe Entry Momentum Tips - kangso.co.kr

Aug 14, 2025

Aug 14, 2025

Combining price and volume data for ProMIS Neurosciences Inc.July 2025 Action & Free Growth Oriented Trading Recommendations - Newser

Aug 14, 2025

Aug 14, 2025

Multi asset correlation models including ProMIS Neurosciences Inc.2025 Trade Ideas & Smart Swing Trading Techniques - Newser

Aug 14, 2025

Aug 14, 2025

ProMIS Neurosciences Reports Q2 2025 Financial Results, Receives FDA Fast Track Designation for PMN310. - AInvest

Aug 14, 2025

Aug 13, 2025

Leading vs lagging indicators on ProMIS Neurosciences Inc. performance2025 Trading Recap & Free Daily Entry Point Trade Alerts - Newser

Aug 13, 2025

Aug 13, 2025

ProMIS Neurosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener

Aug 13, 2025

Aug 13, 2025

ProMIS Neurosciences' Strategic Capital Raise and Long-Term Growth Potential - AInvest

Aug 13, 2025

Aug 13, 2025

Is ProMIS Neurosciences Inc. stock ready for a breakoutJuly 2025 Outlook & Intraday High Probability Setup Alerts - Newser

Aug 13, 2025

Aug 13, 2025

ProMIS Neurosciences: Navigating Capital-Intensive Risks for a Potential Alzheimer's Breakthrough - AInvest

Aug 13, 2025

Aug 13, 2025

ProMIS Neurosciences Reports Q2 GAAP EPS of -$0.29, Cash and Cash Equivalents at $4.5 Million - AInvest

Aug 13, 2025

Aug 13, 2025

ProMIS Neurosciences Inc. stock trend outlook and recovery pathJuly 2025 Price Swings & Weekly Hot Stock Watchlists - Newser

Aug 13, 2025

Aug 13, 2025

ProMIS Neurosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 13, 2025

Aug 13, 2025

Chart overlay techniques for tracking ProMIS Neurosciences Inc.Weekly Trend Summary & High Accuracy Trade Signal Alerts - Newser

Aug 13, 2025

Aug 13, 2025

ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights - Ariva

Aug 13, 2025

Aug 13, 2025

Published on: 2025-08-13 07:52:02 - Newser

Aug 13, 2025

Aug 13, 2025

ProMIS Neurosciences Q2 2025 Financial Results & Corporate Highlights - TradingView

Aug 13, 2025

Aug 13, 2025

ProMIS Neurosciences Inc. SEC 10-Q Report - TradingView

Aug 13, 2025

Aug 13, 2025

ProMIS Neurosciences receives FDA Fast Track designation for PMN310 in Alzheimer's disease. - AInvest

Aug 13, 2025

Aug 13, 2025

ProMIS Neurosciences Announces Q2 2025 Financial Results & Corporate Highlights: FDA Grants Fast Track Designation for PMN310 in Alzheimer’s Disease, PRECISE-AD Trial Progresses on Schedule, and Secures $21.6 Million in Gross Proceeds. - AInvest

Aug 13, 2025

Aug 13, 2025

Analyzing recovery setups for ProMIS Neurosciences Inc. investorsJuly 2025 Analyst Calls & Weekly Stock Breakout Alerts - Newser

Aug 13, 2025

Aug 13, 2025

Multi factor analysis applied to ProMIS Neurosciences Inc.Dividend Hike & Daily Entry Point Trade Alerts - Newser

Aug 13, 2025

Aug 12, 2025

Institutional scanner results for ProMIS Neurosciences Inc.Free Swing Setup With Technical Confirmation - Newser

Aug 12, 2025

Aug 11, 2025

ProMIS Neurosciences PMN 2025Q2 Earnings Preview Upside Ahead on Chinese Market Expansion - AInvest

Aug 11, 2025

Aug 11, 2025

Key metrics from ProMIS Neurosciences Inc.’s quarterly dataSwing Watchlist With Tight Stop Placement - Newser

Aug 11, 2025

Aug 11, 2025

Should I buy ProMIS Neurosciences Inc. stock before earningsFree Daily Top Performing Stock Insights - Newser

Aug 11, 2025

Aug 11, 2025

ProMIS Neurosciences Inc. stock momentum explainedPortfolio Building Plan and Summary Guide - Newser

Aug 11, 2025

Aug 11, 2025

Will ProMIS Neurosciences Inc. stock recover after recent dropTrade Safety Report with Pattern Insights - Newser

Aug 11, 2025

Aug 10, 2025

ProMIS Neurosciences Inc. stock daily chart insightsEntry Opportunity Screener with Confirmation - Newser

Aug 10, 2025

Aug 10, 2025

Is ProMIS Neurosciences Inc. forming a reversal patternSector-Wise Stock Strength Trend Analysis - Newser

Aug 10, 2025

Aug 10, 2025

Can swing trading help recover from ProMIS Neurosciences Inc. lossesStock Forecast Tools for Retail Traders - Newser

Aug 10, 2025

Aug 09, 2025

Intraday pattern recognizer results for ProMIS Neurosciences Inc.Momentum Trend Signal Weekly Recap Summary - Newser

Aug 09, 2025

Aug 09, 2025

How ProMIS Neurosciences Inc. stock performs during market volatilityBuy Strategy with Smart Exit Timing - Newser

Aug 09, 2025